Internal Medicine, Infectious Disease · Youngstown, OH
NPI
1013946821
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
540 Parmalee Ave, Ste. 610
Youngstown, OH, 44510
Phone (330) 744-4369
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
2,132 services
Medicare patients, 2024
422
Average age 74
Drug cost, 2024
$2.8M
1,791 prescriptions
Company payments, 2025
$190
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Indra P Limbu was code 99232 (hospital e&m - subsequent), 1,123 times for 312 patients. In total Indra P Limbu billed 2,132 services in 17 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,123 | 312 | $57.32 | $64K |
| 99231 Hospital E&M - Subsequent | Facility | 338 | 144 | $36.06 | $12K |
| 99222 Hospital E&M - Initial | Facility | 269 | 232 | $92.07 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 175 | 85 | $86.43 | $15K |
| 99223 Hospital E&M - Initial | Facility | 83 | 81 | $126.13 | $10K |
| 99214 Office E&M - Established | Office | 70 | 48 | $81.25 | $5,687 |
| 99213 Office E&M - Established | Office | 38 | 30 | $61.36 | $2,332 |
By year: 2022 $165K for 2,581 services; 2023 $143K for 2,206 services; 2024 $137K for 2,132 services.
Medicare prescription drug claims, 2024
In 2024, the drug Indra P Limbu prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 355 prescriptions and refills. In total Indra P Limbu wrote 1,791 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 355 | 355 | 35 | $1.4M |
| Vancomycin Hcl Generic | 105 | 105 | 24 | $31K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 84 | 92 | Under 11 | $355K |
| Doxycycline Hyclate Generic | 52 | 76 | 29 | $2,279 |
| Isentress Raltegravir Potassium | 48 | 48 | Under 11 | $89K |
| Cephalexin Generic | 45 | 66 | 20 | $1,014 |
| Ertapenem Ertapenem Sodium | 44 | 44 | 12 | $23K |
| Ritonavir Generic | 42 | 48 | Under 11 | $5,115 |
| Tivicay Dolutegravir Sodium | 42 | 42 | Under 11 | $119K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 41 | 41 | Under 11 | $154K |
| Valacyclovir Valacyclovir Hcl | 41 | 49 | Under 11 | $764 |
| Descovy Emtricitabine/Tenofov Alafenam | 39 | 39 | Under 11 | $83K |
| Darunavir Generic | 38 | 38 | Under 11 | $30K |
| Daptomycin Generic | 36 | 36 | 11 | $19K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 36 | 36 | Under 11 | $129K |
Brand drugs: 738 claims; generic drugs: 1,053 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Indra P Limbu $190 ($190 in general payments such as food, travel and fees) from 5 companies. The largest payer was Merck Sharp & Dohme LLC with $101.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.